Put companies on watchlist
AlzChem Group AG
ISIN: DE000A2YNT30
WKN: A2YNT3
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

AlzChem Group AG · ISIN: DE000A2YNT30 · EQS - Company News (87 News)
Country: Germany · Primary market: Germany · EQS NID: 1233024
13 September 2021 03:24PM

AlzChem Group AG aims to enter a new market with Eminex(R), a product for more climate protection in agriculture


DGAP-News: AlzChem Group AG / Key word(s): Market Report
AlzChem Group AG aims to enter a new market with Eminex(R), a product for more climate protection in agriculture

13.09.2021 / 15:24
The issuer is solely responsible for the content of this announcement.


AlzChem Group AG aims to enter a new market with Eminex(R), a product for more climate protection in agriculture

- Distribution to start in 2021 and to be rolled out widely
- Significant reduction of methane and CO2 emissions in livestock farming possible

Trostberg, September 13, 2021 - AlzChem Group AG, a vertically integrated specialty chemicals supplier with a leading market position in selected niche markets, wants to take climate protection in agriculture to a new level with its new product Eminex(R). All over the world, livestock farming has been criticized for its poor environmental performance. In Germany alone, around 240,000 metric tons of methane and considerable amounts of CO2 escape in gaseous form from manure storage tanks every year. These methane emissions in particular are considered critical due to their impact on the climate, but are almost entirely avoidable. This is confirmed by recent studies conducted by DEKRA Assurance Services GmbH and the Leibniz Institute for Agricultural Engineering and Bioeconomy. According to these studies, methane and CO2 emissions during storage can be reduced by 90% to 100% by adding small quantities of the calcium cyanamide-based processing agent Eminex(R).

Andreas Niedermaier, CEO of AlzChem Group AG: "With Eminex(R) as an additive for blocking methane and CO2 emissions in agriculture, we are opening up a completely new global market. At the same time, agriculture is already an extremely well-developed target group for us, because we have a strong sales presence in this sector through our fertilizers. The conditions for market success are therefore excellent. We have the structural prerequisites and farmers are given a simple opportunity to make a significant leap in climate protection. The market could experience additional momentum above all if appropriate efforts were also made on the regulatory side."

Eminex(R) will be available in Germany and Austria from September 2021. Gradually, Switzerland and other European markets with intensive livestock farming will also be developed. Of particular interest to farmers is the fact that climate-protecting measures with Eminex(R) do not require any structural measures or investments in the storage and collection containers. In the future, farmers will thus be able to make a significant contribution to reducing the environmental impact associated with livestock farming quickly and without investment.

The AlzChem Group itself invests around EUR 19 million a year in measures to improve climate protection, according to the figures in the new Environmental Statement 2021. For example, in recent years, it has succeeded in reducing carbon dioxide emissions by 50,000 tons a year. In addition, the company aims to exceed the requirements of the German Federal Constitutional Court on the Climate Protection Act of April 29, 2021, via compensation measures for its own products. Eminex(R) is an important building block in this. In the medium term, the company has set itself the goal of becoming completely greenhouse gas neutral.

About AlzChem
AlzChem is a globally active specialty chemicals company that is predominantly among the market leaders in its fields of activity. AlzChem benefits in particular from the three very different global developments of climate change, population growth and longer life expectancy. In order to achieve the resulting social goals, AlzChem products can offer attractive solutions with a wide range of different applications.

The company sees interesting growth prospects for itself especially in the areas of human and animal nutrition and agriculture. As a result of population growth, it is necessary to achieve efficient food production. Pharmaceutical raw materials and our creatine products can contribute to healthy aging as life expectancy increases. AlzChem is facing up to the goal of sustainability arising from climate change in the field of renewable energies and across the entire company. The fields of fine chemicals and metallurgy offer just as great a perspective.

The broad product range of AlzChem Group AG includes dietary supplements, precursors for corona tests and pharmaceutical raw materials. These products are our company's response to global trends and developments. AlzChem is ideally positioned in this regard and sees itself as well equipped for an environmentally oriented future and global developments.

The company employs around 1,630 people at four production sites in Germany and one plant in Sweden, as well as two sales companies in the USA and China. In 2020, AlzChem generated consolidated sales of around EUR 379 million and EBITDA of around EUR 53.8 million.



Contact:
Sabine Sieber
Head of Investor Relations & Communications


13.09.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: AlzChem Group AG
Dr.-Albert-Frank-Str. 32
83308 Trostberg
Germany
Phone: +498621862888
Fax: +49862186502888
E-mail: ir@alzchem.com
Internet: www.alzchem.com
ISIN: DE000A2YNT30
WKN: A2YNT3
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart
EQS News ID: 1233024

 
End of News DGAP News Service

1233024  13.09.2021 

fncls.ssp?fn=show_t_gif&application_id=1233024&application_name=news&site_id=boersengefluester_html
Visual performance / price development - AlzChem Group AG
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.